Insiders · VRTX

Mark E. Bunnage

EVP, Chief Scientific Officer at Vertex Pharmaceuticals Inc / Ma (VRTX) since February 2026

Mark E. Bunnage has filed 6 insider reports with the SEC since February 2026, as EVP and chief Scientific Officer at Vertex Pharmaceuticals Inc / Ma (VRTX). In the last 12 months Mark E. Bunnage sold $3M of stock on the open market. In the latest filing, on May 19, 2026, Mark E. Bunnage sold 33 shares of Vertex Pharmaceuticals Inc / Ma (VRTX) for $15K at an average of $453.45.

Filings
6
Companies
1
Bought on market
None
Sold on market
$3M

Companies where Mark E. Bunnage is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Vertex Pharmaceuticals Inc / Ma logo
VRTX
Vertex Pharmaceuticals Inc / Ma
EVP, Chief Scientific Officersince February 20267,284$3M$536.45May 19, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Mark E. Bunnage with

Other insiders at the same companies

Questions about Mark E. Bunnage

What is Mark E. Bunnage's role at Vertex Pharmaceuticals Inc / Ma?
Mark E. Bunnage reports to the SEC as EVP and chief Scientific Officer at Vertex Pharmaceuticals Inc / Ma (VRTX), according to the latest filing on May 19, 2026.
How many shares does Mark E. Bunnage own?
After the latest filing that states it, Mark E. Bunnage directly owned 7,284 shares of Vertex Pharmaceuticals Inc / Ma (VRTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark E. Bunnage bought or sold stock recently?
The most recent open-market sale was on May 15, 2026: sold 33 shares of Vertex Pharmaceuticals Inc / Ma (VRTX) for $15K at an average of $453.45.
How do I get alerts when Mark E. Bunnage files?
Follow Mark E. Bunnage on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mark E. Bunnage (SEC CIK 0002100735). Totals count each trade once, skipping amendments whose original is on file, from Feb 3, 2026 on. View on SEC EDGAR